Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
Titel:
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
Auteur:
Loomba, Rohit Abdelmalek, Manal F Armstrong, Matthew J Jara, Maximilian Kjær, Mette Skalshøi Krarup, Niels Lawitz, Eric Ratziu, Vlad Sanyal, Arun J Schattenberg, Jörn M Newsome, Philip N
Verschenen in:
The Lancet gastroenterology & hepatology
Paginering:
Jaargang 8 () nr. 6 pagina's 511-522
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license